Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Carabersat. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCC9 known ✓ | O60706 | 5/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carabersat SCHEMBL5317948 | 1.00 | ABCC9 (0.64) | ABCC9 | |
| Carabersat SCHEMBL261192 | 0.99 | ABCC9 (0.62) | ABCC9 | |
| Carabersat SCHEMBL27394684 | 0.99 | ABCC9 (0.62) | ABCC9 | |
| Carabersat SCHEMBL27418709 | 0.99 | ABCC9 (0.62) | ABCC9 | |
| Carabersat SCHEMBL3301553 | 0.99 | ABCC9 (0.62) | ABCC9 | |
| Carabersat SCHEMBL3300409 | 0.99 | ABCC9 (0.62) | ABCC9 | |
| Carabersat SCHEMBL9287969 | 0.99 | ABCC9 (0.62) | ABCC9 | |
| Carabersat SCHEMBL3308650 | 0.99 | ABCC9 (0.62) | ABCC9 | |
| Carabersat SCHEMBL3301548 | 0.99 | ABCC9 (0.62) | ABCC9 | |
| Carabersat SCHEMBL29373163 | 0.99 | ABCC9 (0.62) | ABCC9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1534250-A4 | ELECTROSPUN AMORPHOUS PHARMACEUTICAL COMPOSITIONS | SMITHKLINE BEECHAM CORP (US) | 2007-07-04 | — | — | EP | claimed |
| US-20060013869-A1 | Electrospun amorphous pharmaceutical compositions | IGNATIOUS FRANCIS | 2006-01-19 | — | — | US | claimed |
| EP-1534250-A2 | ELECTROSPUN AMORPHOUS PHARMACEUTICAL COMPOSITIONS | SmithKline Beecham Corporation (US) | 2005-06-01 | — | — | EP | claimed |
| WO-2004014304-A2 | ELECTROSPUN AMORPHOUS PHARMACEUTICAL COMPOSITIONS | SMITHKLINE BEECHAM CORPORATION (US) | 2004-02-19 | — | — | WO | claimed |
| EP-1853262-A1 | PHARMACEUTICAL COMPOSITION COMPRISING AMORPHOUS ROSIGLITAZONE | SMITHKLINE BEECHAM CORPORATION (US) | 2007-11-14 | — | — | EP | disclosed |
| EP-1534250-A4 | ELECTROSPUN AMORPHOUS PHARMACEUTICAL COMPOSITIONS | SMITHKLINE BEECHAM CORP (US) | 2007-07-04 | — | — | EP | disclosed |
| WO-2006090150-A1 | PHARMACEUTICAL COMPOSITION COMPRISING AMORPHOUS ROSIGLITAZONE | SMITHKLINE BEECHAM CORPORATION (US) | 2006-08-31 | — | — | WO | disclosed |
| US-20060083784-A1 | Amorphous pharmaceutical compositions | SMITHKLINE BEECHAM CORPORATION | 2006-04-20 | — | — | US | disclosed |
| US-20060013869-A1 | Electrospun amorphous pharmaceutical compositions | IGNATIOUS FRANCIS | 2006-01-19 | — | — | US | disclosed |
| EP-1534250-A2 | ELECTROSPUN AMORPHOUS PHARMACEUTICAL COMPOSITIONS | SmithKline Beecham Corporation (US) | 2005-06-01 | — | — | EP | disclosed |
| WO-2004014304-A2 | ELECTROSPUN AMORPHOUS PHARMACEUTICAL COMPOSITIONS | SMITHKLINE BEECHAM CORPORATION (US) | 2004-02-19 | — | — | WO | disclosed |